SCHEMBL12470518

SCHEMBL12470518

COc1ccc(-c2nc3cc(C(=O)O)ccc3[nH]2)c(OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.54
TP53 P04637 1/20 0.54
MAPT P10636 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
CHEK2 O96017 4/20 0.54
PDE2A O00408 1/20 0.51
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
ALPL P05186 1/20 0.47
CSNK2A1 P68400 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
AMY1A P0DUB6 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11019245 0.86 CHEK2 (0.44) POLBTP53MAPTTDP1CHEK2
SCHEMBL11017574 0.86 NPSR1 (0.45) POLBTP53MAPTTDP1CHEK2
SCHEMBL11020731 0.85 NPC1 (0.44) POLBTP53MAPTTDP1CHEK2
SCHEMBL11374443 0.84 GUSB (0.53) POLBTP53MAPTTDP1CHEK2
SCHEMBL11017837 0.83 CA2 (0.46) POLBTP53MAPTTDP1CHEK2
SCHEMBL1662758 0.83 CHEK2 (0.76) MAPTCHEK2KDM4EHPGDMEN1
SCHEMBL11017897 0.82 PDE4A (0.44) POLBTP53MAPTTDP1CHEK2
SCHEMBL11017892 0.82 MAPT (0.44) POLBTP53MAPTTDP1CHEK2
SCHEMBL11021534 0.82 CHEK2 (0.41) POLBTP53MAPTTDP1CHEK2
SCHEMBL12470674 0.81 PDE2A (0.56) POLBTP53MAPTPDE2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO claimed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US disclosed
US-9155690-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2015-10-13 US disclosed
US-8889881-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor Pusan National University Industry —University Cooperation Foundation (KR) 2014-11-18 US disclosed
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR Pusan National University Indusrtyuniversity (KR) 2014-02-06 US disclosed
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PPARG, PPARA, TYR POLB 152/4885TP53 1659/4885MAPT 1956/4885
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR PPARG, PPARA, PPARD POLB 255/4885TP53 1453/4885MAPT 2700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.